Table.
Sociodemographic and obstetric characteristics of 9,529 HIV-infected women eligible for cART initiation during pregnancy in Lusaka, Zambia 2009-2013.
| Characteristic | Small for gestational age a N(%) or Median (IQR) |
Normal for gestational age a N(%) or Median (IQR) |
Missing Data N (%) |
|---|---|---|---|
| N=583 (8) | N=6,814 (92) | N=9,529 | |
| Age | 27 (23, 31) | 27 (23, 31) | 17 (0) |
| Education | 1,201 (13) | ||
| Primary or None | 252 (50) | 2,720 (46) | |
| Secondary or higher | 255 (50) | 3,223 (54) | |
| Parity | 903 (10) | ||
| 0 | 145 (27) | 1,150 (19) | |
| 1 | 140 (26) | 1,571 (24) | |
| 2 | 108 (20) | 1,517 (25) | |
| 2+ | 146 (27) | 1,912 (31) | |
| BMI | 23 (21, 25) | 23 (22, 25) | 3,130(33) |
| CD4 count | 230 (156, 286) | 239 (168, 297) | 0 (0) |
| Hemoglobin | 11 (10, 12) | 11 (10, 12) | 759 (8) |
| Syphilis screening | 0 (0) | ||
| Non-reactive | 372 (64) | 4,246 (62) | |
| Reactive | 28 (5) | 331 (5) | |
| Not tested | 183 (31) | 2,237 (33) | |
| Tuberculosis | 2,590 (27) | ||
| No | 410 (97) | 4,380 (97) | |
| Yes | 14 (3) | 137 (3) | |
| IPT b for Malaria | 0 (0) | ||
| None | 154 (26) | 1,701 (25) | |
| 1 dose SP | 301 (52) | 3,543 (52) | |
| 2 doses SP | 82 (14) | 1,086 (16) | |
| 3 doses SP | 46 (8) | 478 (7) | |
| Number of antenatal care visits | 0 (0) | ||
| 1 | 298 (51) | 3,607 (54) | |
| 2 | 141 (24) | 1,734 (26) | |
| 3 | 97 (17) | 978 (14) | |
| ≥4 | 47 (8) | 432 (6) | |
| Previous preterm birth | 0 (0) | ||
| No | 564 (96.7) | 6,602 (96.9) | |
| Yes | 19 (3.3) | 212 (3.1) | |
a
Missing outcomes: SGA 2,132 (22.4%), preterm birth 1,399 (14.7%).
b
cART : combination antiretroviral therapy
BMI = body mass index; IPT: intermittent presumptive therapy; SP: sulfadoxine-pyrmethamine